A comparative analysis of the dynamics of cash payments of families for medical and pharmaceutical services among the total health spending in Ukraine, Azerbaijan, Armenia, Georgia
DOI:
https://doi.org/10.24959/sphhcj.19.171Keywords:
medical care, healthcare, healthcare costs, cash costs for healthcare, pharmaceutical care, CIS countriesAbstract
Aim. To conduct a comparative analysis of the dynamics of changes in cash expenditures (%) of families associated with medical and pharmaceutical services among the total health expenditures inUkraine,Azerbaijan,Armenia andGeorgia.
Materials and methods. The studies used data from the World Health Organization and its European Regional Office for a group of the reference countries (Ukraine,Azerbaijan,Armenia,Georgia). Both general theoretical (historical, analytical-comparative, systemic, logical, hypothetical-deductive) and applied methods applied in organizational and economic research in pharmacy were used.
Results. It was found that the average value of the household cash expenditures (%) among the total health expenditures for the group of reference countries was equal to:Azerbaijan – 66.94 %;Armenia – 61.59 %;Georgia – 73.74 %;Ukraine – 39.24 %. It was proven that the positive, from the socio-economic point of view, dynamics of a decrease in the indicators studied was observed inArmenia andGeorgia (kaver.value = 0.99 and kaver.value = 0.98, respectively). In 2014, compared to the base (1995) data, the growth of indicators analyzed in Azerbaijan amounted to + 8.6 %, in Armenia –19.8 %, in Georgia –38.2 %, and in Ukraine +88, 6 % The most pronounced positive changes in the dynamics of indicators studied were observed in Georgia, and negative ones in Ukraine. For example, inUkraine there was an increase in data from 24.5 % (1995) to 46.2 % (2014). InArmenia andAzerbaijan, the dynamics of the indicators analyzed were characterized by the complex (zigzag) nature of the changes in the retrospective of years.
Conclusions. According to the research, it can be argued that among the group of the reference countries onlyGeorgia has shown positive trends in strengthening the role of the state or other public institutions in financially supporting the process of providing medical and pharmaceutical services to the country’s population.
References
Burbela A. L. (2017) Naukovyi visnyk Uzhhorodskoho natsionalnoho universytetu, 14 (1), 37–40.
Podpruzhnikov, Yu. V., Ishmukhametov, A. A., Nemchenko, A. S. et al. (2015). Khrestomatiia farmatsevticheskogo kachestva / – M. : Gruppa Remedium. – 432 s.
Panfilova, H. L., Kharchenko, D. S., Sokurenko, I. A. (2016). Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii, 4, 52–60. doi: 10.24959/uekj.16.44.
Hnydiuk, I. V. (2015). Economic Annals–XXI, 155 (11–12), 73–77.
Lobas, M. V. (2016). Ukraina. Zdorov’ia natsii, 4/1 (41), 150–155.
Nazarov, D. S. (2014). Aktualni problemy mizhnarodnykh vidnosyn, 119 (1), 170–180.
Kniazevych, V. M., Zhalilo, L. I. (2015). Visnyk Natsionalnoi akademii derzhavnoho upravlinnia, 3, 99–104.
Sherstiuk, N. S., Sokolov, A. V. (2016). Ekonomika i suspilstvo, 5, 316–319.
Tereshchenko L., Zhirova S. (2019). Analysis of the dynamics of expenditures on pharmaceutical support of population in Ukraine, Belarus Republic and in European Union. ScienceRise: Pharmaceutical Science,4 (20), 10–14. doi: 10.15587/2519-4852.2019.177193.
Borushhak, I. Suchasni tendentsii rozvytku farmatsevtychnoho rynku Ukrainy v umovakh hlobalnykh strukturnykh zrushen. Available at: http://dspace.tneu.edu.ua/bitstream/316497/23083/1/141–144.pdf (Accessed: 25.11.2019).
EAEU & CIS Pharmaceutical Forum 2019, 27–28 February. Available at: https://www.plgs–spain.com/LinkClick.aspx?fileticket=y7XHYt485vo%3D&portalid=0 (Accessed: 25.11.2019).
Simkute, Olivija. CIS and Eurasian Economic Union: high Pharma industry interest and new legislation. Available at: https://biomapas.eu/cis–and–eurasian–economic–union–high–pharma–industry–interest–and–new–legislation/ (Accessed: 25.11.2019).
The Common Market of Medicines within the Eurasian Economic Union was presented in the European Union. Available at: https://www.efpia.eu/news–events/the–efpia–view/statements–press–releases/04052018–the–common–market–of–medicines–within–the–eurasian–economic–union–was–presented–in–the–european–union/ (Accessed: 25.11.2019).
Pharmacy workforce predicted to grow year on year in new report. Press FIP – International Pharmaceutical Federation. Available at: https://fip.org/newsandpublications_press (Accessed: 25.11.2019).
Pharmacy Workforce Intelligence: Global Trends Report 2018 International Pharmaceutical Federation (FIP). (2018). Available at: https://fip.org/files/fip/PharmacyEducation/Workforce_Report_2018.pdf
(Accessed: 25.11.2019).
VOZ, Evropeiskoe regionalnoe biuro. Evropeiskii portal informatsii. Available at: https://gateway.euro.who.int/ru/indicators/hfa_584–6860–private–households–out–of–pocket–payments–on–health–as–of–total–health–expenditure/visualizations/#id=19679 (Accessed: 25.11.2019).
Zdravookhraneniia Azerbaidzhana. Available at: http://azerbaijan.az/portal/Society/Health/publicHealth_r.html (Accessed: 25.11.2019).
Downloads
Published
Issue
Section
License
Copyright (c) 2019 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
